logo
logo
SEER stock ticker logo

Seer, Inc.

NASDAQ•SEER
CEO: Dr. Omid C. Farokhzad M.D., Ph.D.
Sector: Healthcare
Industry: Biotechnology
Listing Date: 2020-12-04
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Contact Information
3800 Bridge Parkway, Suite 102, Redwood City, CA, 94065, United States
650-453-0000
seer.bio
Market Cap
$94.57M
P/E (TTM)
-1.4
24.5
Dividend Yield
--
52W High
$2.41
52W Low
$1.65
52W Range
9%
Rank54Top 78.1%
2.7
F-Score
Modified Piotroski Analysis
Based on 7-year fundamentals
Weak • 2.7 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2019-2025

Deep Research

Financials
Earnings Calls
Reports
News
Income Statement
Balance Sheet
Cash Flow Statement
Ratios
% Chg.
Income Statement
LTM
No Data